Langebrake, Claudia <br/><br/>
Minimising the long-term adverse effects of childhood leukaemia therapy.  [electronic resource] 

 -  Drug safety  2002 
 - 1057-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-200225150-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkylating Agents--adverse effects<br/>Anthracyclines--adverse effects<br/>Antimetabolites--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Asparaginase--adverse effects<br/>Asparagine--adverse effects<br/>Cardiovascular Diseases--chemically induced<br/>Child<br/>Clinical Trials as Topic<br/>Glucocorticoids--adverse effects<br/>Gonadal Disorders--chemically induced<br/>Humans<br/>Leukemia--drug therapy<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Osteonecrosis--chemically induced<br/>Podophyllotoxin--adverse effects<br/>Polyethylene Glycols--adverse effects<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Tretinoin--adverse effects<br/>Vinca Alkaloids--adverse effects